Search

Search Constraints

You searched for: Author/Creator Satoh, Takeaki

Search Results

1. Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study. Issue 40 (7th October 2022)

2. Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non‐cirrhotic patients with chronic hepatitis C virus genotype 1b infection. Issue 12 (December 2015)

3. Comparative safety study on severe anemia by simeprevir versus telaprevir‐based triple therapy for chronic hepatitis C. Issue 8 (August 2015)

4. Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan. Issue 6 (19th June 2019)

5. Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals. (25th June 2020)

6. Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis. Issue 3 (10th June 2016)

7. Efficacy and safety of splenectomy in telaprevir‐based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis. Issue 9 (September 2014)

8. Efficacy of interferon‐beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C. Issue 3 (2nd September 2015)

9. Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study. Issue 6 (9th April 2019)

10. Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B. Issue 5 (7th November 2011)